Latest News and Press Releases
Want to stay updated on the latest news?
-
The Notice has no Immediate Effect on the Listing of the Company’s Securities on NASDAQ and the Company Expects to Regain Compliance within the Applicable Deadline. Nashville, TN, Nov. 27, 2024 ...
-
LOS GATOS, Calif., May 25, 2023 (GLOBE NEWSWIRE) -- Aridis Pharmaceuticals, Inc. (Nasdaq: ARDS) (“Aridis” or the “Company”), a biopharmaceutical company, announced today that it received a notice...